In this institutional application by Boston University School of Medicine, we propose to establish a unified instrument facility bringing together existing equipment (oligonucleotide synthesizer, amino acid analyzers) and adding new state-of-the-art equipment in a core with trained personnel who will provide a service to a variety of research projects. We are requesting funding to purchase a peptide synthesis system with three reaction vessels and an HPLC system for peptide purification. The instruments will be utilized by four major research groups: the Cardiovascular Institute, and the Departments of Medicine, Biochemistry, and Biophysics. Major uses will involve: 1) synthesis of angiotensin inhibitor, synthesis of agonist and antagonist of bradykinin and vasopressin receptors (Dr. Gavras); 2) synthesis of peptides recognized by the platelet (GPIIb-IIIa) and other cell adhesion receptors termed integrins, synthesis of peptides corresponding to the platelet receptor binding domains of fibronectin, plasmin, urokinase, tissue plasminogen activator and thrombospondin (Dr. Plow); 3) synthesis of peptides corresponding to structural or functional domains of apolipoproteins (Dr. Small and associates). The instruments will be installed in the newly created molecular biology research facilities constructed with NIH funding (HL35669). The P.I. will be responsible for the overall operation of these instruments. Dr. Lammek, an accomplished peptide chemist will be responsible for the daily operation of the peptide synthesizer and the HPLC. After two years of support from the University, most of the financial support for the operation of the instruments will be obtained from existing or new research grants. Research activities have expanded dramatically at the School of Medicine in the past few years with several new faculty recruits. Emphasis has been placed on the utilization of molecular biology approaches to study problems pertinent to hypertension, atherosclerosis, and pulmonary disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biomedical Research Support Grants (S07)
Project #
2S07RR005857-10
Application #
3516849
Study Section
Special Emphasis Panel (NSS)
Project Start
1981-04-01
Project End
1991-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
10
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
Schools of Pharmacy
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Hamelin, B A; Blouin, R A; Wolf, K M et al. (1992) In vivo and in vitro beta 2-adrenergic receptor responsiveness in young and elderly asthmatics. Pharmacotherapy 12:376-82
Galante, L J; Brinkley, M A; Lodder, R A (1992) Bacterial monitoring in vials using a spectrophotometric assimilation method. Pharm Res 9:357-64
Britto, M R; McKean, H E; Bruckner, G G et al. (1991) Polymorphisms in oxidative drug metabolism: relationship to food preference. Br J Clin Pharmacol 32:235-7
St Pyrek, J; Lee, S P; Thomsen, L et al. (1991) Bile acids of marsupials. 2. Hepatic formation of vulpecholic acid (1 alpha,3 alpha,7 alpha-trihydroxy-5 beta-cholan-24-oic acid) from chenodeoxycholic acid in a marsupial, Trichosurus vulpecula (Lesson). J Lipid Res 32:1417-27
Soltis, E E; Newman, P S (1991) Age-dependent salt-induced hypertension in the rat: prevention with DSP-4, a selective noradrenergic neurotoxin. Clin Exp Hypertens A 13:557-72
Lai, Y L (1991) Role of the axon reflex in capsaicin-induced bronchoconstriction in guinea pigs. Respir Physiol 83:35-46
Zannikos, P N; Li, W I; Drennen, J K et al. (1991) Spectrophotometric prediction of the dissolution rate of carbamazepine tablets. Pharm Res 8:974-8
Guttendorf, R J; Britto, M; Blouin, R A et al. (1990) Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism. Br J Clin Pharmacol 29:373-80
Galante, L J; Brinkley, M A; Drennen, J K et al. (1990) Near-infrared spectrometry of microorganisms in liquid pharmaceuticals. Anal Chem 62:2514-21
Clifton, G D; Hunt, B A; Patel, R C et al. (1990) Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses. Am Rev Respir Dis 141:575-9

Showing the most recent 10 out of 21 publications